8-KCorporate ChangesExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Bylaw Amendment (Oct 15, 2013)

Filed October 15, 2013For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) announced an amendment to its Amended and Restated By-laws, effective October 10, 2013. The primary changes involve the delegation of authority for signing company instruments and the designation of an exclusive forum for stockholder litigation. These amendments, while procedural, are significant for corporate governance and the legal recourse available to shareholders.

Key Highlights

  • 1President granted authority to authorize employees to sign various company documents, potentially streamlining operational execution.
  • 2Delaware Court of Chancery designated as the exclusive forum for certain stockholder lawsuits.
  • 3This designation aims to centralize and potentially reduce the cost and complexity of litigation concerning the company.
  • 4The amendments were approved by the Board of Directors on October 10, 2013.
  • 5The updated by-laws are incorporated by reference as Exhibit 3.1 to the 8-K filing.

Frequently Asked Questions

The amendments aim to enhance operational efficiency by allowing the President to delegate signing authority for company documents and to establish a specific, exclusive forum (Delaware Court of Chancery) for stockholder lawsuits, potentially simplifying and standardizing legal proceedings.

Shareholders will generally be required to bring certain lawsuits concerning Quest Diagnostics in the Delaware Court of Chancery. This may streamline litigation by consolidating cases in one jurisdiction, potentially leading to more predictable outcomes and management of legal costs.

The amendment regarding signing authority could streamline certain processes by allowing the President to authorize others. However, for most employees, the direct impact on their day-to-day tasks is likely to be minimal, though it indicates a move towards potentially more efficient authorization protocols.

The Amended and Restated By-Laws of Quest Diagnostics Incorporated, as amended effective October 10, 2013, are filed as Exhibit 3.1 to this Current Report on Form 8-K and are incorporated herein by reference.